AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011
Mar 4, 2011
30339_dirs_2011-03-04_d41fb361-12be-414b-96e6-ff3ada5ae962.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-03-03
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-03 | Common Stock | M | 125000.0000 | $13.9925 | Acquired | 403648.9350 | Direct |
| 2011-03-03 | Common Stock | F | 76038.0000 | $41.0700 | Disposed | 327610.9350 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-03 | Stock Option (Right to Buy) | $13.9925 | M | 125000.0000 | Disposed | 2012-04-30 | Common Stock (125000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1198.6459 | Indirect |
| Common Stock | 24158.1337 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12